Platelet Inhibition by Sertraline and N-Desmethylsertraline: A Possible Missing Link Between Depression, Coronary Events, and Mortality Benefits of Selective Serotonin Reuptake Inhibitors
- 31 May 2001
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 43 (5) , 453-461
- https://doi.org/10.1006/phrs.2001.0817
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- Exaggerated platelet reactivity in major depressionAmerican Journal of Psychiatry, 1996
- Depression is also'a risk factorBMJ, 1996
- Depression and 18-Month Prognosis After Myocardial InfarctionCirculation, 1995
- Depression Following Myocardial InfarctionJAMA, 1993
- Flow Cytometric Measurement of Platelet Function and Reticulated PlateletsAnnals of the New York Academy of Sciences, 1993
- Alteration by a plasma factor of platelet aggregation and 5HT uptake in depressionBiological Psychiatry, 1992
- Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)The American Journal of Cardiology, 1990
- Major depressive disorder in coronary artery diseaseThe American Journal of Cardiology, 1987
- Factors Influencing Platelet Aggregation in Whole BloodAmerican Journal of Clinical Pathology, 1986